MXPA01013276A - Materiales biologicamente activos. - Google Patents

Materiales biologicamente activos.

Info

Publication number
MXPA01013276A
MXPA01013276A MXPA01013276A MXPA01013276A MXPA01013276A MX PA01013276 A MXPA01013276 A MX PA01013276A MX PA01013276 A MXPA01013276 A MX PA01013276A MX PA01013276 A MXPA01013276 A MX PA01013276A MX PA01013276 A MXPA01013276 A MX PA01013276A
Authority
MX
Mexico
Prior art keywords
polymer
dextrin
drug conjugate
further characterized
agent
Prior art date
Application number
MXPA01013276A
Other languages
English (en)
Spanish (es)
Inventor
Ruth Duncan
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914187.1A external-priority patent/GB9914187D0/en
Priority claimed from GBGB9930252.3A external-priority patent/GB9930252D0/en
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Publication of MXPA01013276A publication Critical patent/MXPA01013276A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA01013276A 1999-06-18 2000-06-19 Materiales biologicamente activos. MXPA01013276A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914187.1A GB9914187D0 (en) 1999-06-18 1999-06-18 Biologically active materials
GBGB9930252.3A GB9930252D0 (en) 1999-12-22 1999-12-22 Biologically active molecules
PCT/GB2000/002216 WO2000078355A2 (en) 1999-06-18 2000-06-19 Biologically active materials

Publications (1)

Publication Number Publication Date
MXPA01013276A true MXPA01013276A (es) 2002-06-04

Family

ID=26315678

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01013276A MXPA01013276A (es) 1999-06-18 2000-06-19 Materiales biologicamente activos.

Country Status (11)

Country Link
US (1) US6818630B1 (enExample)
EP (1) EP1198253A2 (enExample)
JP (1) JP2003504312A (enExample)
AU (1) AU783886B2 (enExample)
CA (1) CA2374548A1 (enExample)
HK (1) HK1047884A1 (enExample)
IL (1) IL146795A0 (enExample)
MX (1) MXPA01013276A (enExample)
NO (1) NO20016147L (enExample)
NZ (1) NZ515999A (enExample)
WO (1) WO2000078355A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
WO2002020663A2 (en) 2000-09-06 2002-03-14 Ap Pharma, Inc. Degradable polyacetal polymers
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
DE10129369C1 (de) 2001-06-21 2003-03-06 Fresenius Kabi De Gmbh Wasserlösliches, einen Aminozucker aufweisendes Antibiotikum in Form eines Pol ysaccharid-Konjugats
DE60323936D1 (de) 2002-01-14 2008-11-20 Gen Hospital Corp Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
US8030459B2 (en) 2002-07-19 2011-10-04 The General Hospital Corporation Oxime conjugates and methods for their formation and use
DE60323756D1 (de) 2002-10-08 2008-11-06 Fresenius Kabi De Gmbh Pharmazeutisch aktive oligosaccharid-conjugate
US7947261B2 (en) * 2003-05-23 2011-05-24 Nektar Therapeutics Conjugates formed from polymer derivatives having particular atom arrangements
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
DE602004032553D1 (de) * 2003-09-05 2011-06-16 Gen Hospital Corp Polyacetal-arzneimittelkonjugate als freisetzungssystem
PA8853201A1 (es) 2008-12-10 2010-07-27 Mersana Therapeutics Inc Formulaciones farmaceuticas de conjugados de camtotecina-polimero biocompatibles biodegradables
KR102366322B1 (ko) 2020-07-31 2022-02-22 주식회사 다산네트웍스 전기자전거 주행시스템

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69103503T2 (de) * 1990-09-28 1995-01-05 Mercian Corp Adriamycinderivate.
WO1995005199A1 (en) * 1993-08-19 1995-02-23 Dextran Products Limited Pharmaceutical preparation and a process for making same
IT1281877B1 (it) 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
US6338843B1 (en) * 1997-06-12 2002-01-15 Ml Laboratories Biologically active materials

Also Published As

Publication number Publication date
JP2003504312A (ja) 2003-02-04
NZ515999A (en) 2004-03-26
AU5413000A (en) 2001-01-09
HK1047884A1 (zh) 2003-03-14
AU783886B2 (en) 2005-12-22
CA2374548A1 (en) 2000-12-28
NO20016147L (no) 2002-01-29
NO20016147D0 (no) 2001-12-17
WO2000078355A3 (en) 2002-02-21
EP1198253A2 (en) 2002-04-24
US6818630B1 (en) 2004-11-16
IL146795A0 (en) 2002-07-25
WO2000078355A2 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
US7186413B2 (en) Hydrogels and water soluble polymeric carriers for drug delivery
Lai et al. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy
Etrych et al. HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity
Etrych et al. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours
Etrych et al. Biodegradable star HPMA polymer–drug conjugates: Biodegradability, distribution and anti-tumor efficacy
Duncan Development of HPMA copolymer–anticancer conjugates: clinical experience and lessons learnt
Kostka et al. HPMA-based star polymer biomaterials with tuneable structure and biodegradability tailored for advanced drug delivery to solid tumours
US20020155992A1 (en) Poly (dipeptide) as a drug carrier
EP2063914B1 (en) Grafted macromolecular conjugates of doxorubicin with anticancer activity and method of their preparation
WO2000066091A1 (en) Amplification of folate-mediated targeting to tumor cells using polymers
CA2376175A1 (en) Vitamin directed dual targeting therapy
US6818630B1 (en) Biologically active materials
US6338843B1 (en) Biologically active materials
Inoue et al. CM-dextran-polyalcohol-camptothecin conjugate: DE-310 with a novel carrier system and its preclinical data
Souček et al. Poly [N-(2-hydroxypropyl) methacrylamide] conjugates of bovine pancreatic ribonuclease (RNase A) inhibit growth of human melanoma in nude mice
US20040121954A1 (en) Poly(dipeptide) as a drug carrier
WO2002083154A1 (en) Use of cationic dextran derivatives for protecting dose-limiting organs
CN102652836A (zh) 靶向释药的抗癌蛋白质或多肽聚合物前药及其制备方法
Goddard et al. Biodegradation of drug-modified polymers in drug delivery-a critical analysis
Conjugates Research Journal of Pharmaceutical, Biological and Chemical
AU2004201277A1 (en) Amplification of folate-mediated targeting to tumor cells using polymers